GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...
GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...
Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...